Epithelial-to-mesenchymal transition promotes tubulin detyrosination and microtentacles that enhance endothelial engagement - Wikidata - wikimedia - TriplyDB

Epithelial-to-mesenchymal transition promotes tubulin detyrosination and microtentacles that enhance endothelial engagement

Epithelial-to-mesenchymal transition promotes tubulin detyrosination and microtentacles that enhance endothelial engagement

http://www.wikidata.org/entity/Q34141959

about

Epithelial cell dissemination and readhesion: analysis of factors contributing to metastasis formation in breast cancer The chemical complexity of cellular microtubules: tubulin post-translational modification enzymes and their roles in tuning microtubule functions Epithelial-mesenchymal plasticity in carcinoma metastasis Putative biomarkers and targets of estrogen receptor negative human breast cancer Sperm Associated Antigen 6 (SPAG6) Regulates Fibroblast Cell Growth, Morphology, Migration and Ciliogenesis.Anti-migratory effect of vinflunine in endothelial and glioblastoma cells is associated with changes in EB1 C-terminal detyrosinated/tyrosinated status Tubulin tyrosine ligase structure reveals adaptation of an ancient fold to bind and modify tubulin Structural basis of tubulin tyrosination by tubulin tyrosine ligase Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer Lipid tethering of breast tumor cells enables real-time imaging of free-floating cell dynamics and drug response.ROCK inhibition promotes microtentacles that enhance reattachment of breast cancer cells Microtubules and their role in cellular stress in cancer Epithelial-mesenchymal transition stimulates human cancer cells to extend microtubule-based invasive protrusions and suppresses cell growth in collagen gel.Tumor suppressor RARRES1 interacts with cytoplasmic carboxypeptidase AGBL2 to regulate the α-tubulin tyrosination cycle α-Tubulin acetylation elevated in metastatic and basal-like breast cancer cells promotes microtentacle formation, adhesion, and invasive migration.Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer Intercellular adhesion: mechanisms for growth and metastasis of epithelial cancers.Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancer Epithelial to mesenchymal transition is associated with rapamycin resistance Pharmacologic regulation of AMPK in breast cancer affects cytoskeletal properties involved with microtentacle formation and re-attachment Interplay of Stem Cell Characteristics, EMT, and Microtentacles in Circulating Breast Tumor Cells.Prefoldin 1 promotes EMT and lung cancer progression by suppressing cyclin A expression.Nonhypoxic regulation and role of hypoxia-inducible factor 1 in aromatase inhibitor resistant breast cancer.Parthenolide and costunolide reduce microtentacles and tumor cell attachment by selectively targeting detyrosinated tubulin independent from NF-κB inhibition.Curcumin targets breast cancer stem-like cells with microtentacles that persist in mammospheres and promote reattachment.Mechanisms of Chromosome Congression during Mitosis.A real-time electrical impedance based technique to measure invasion of endothelial cell monolayer by cancer cells.Role of cellular cytoskeleton in epithelial-mesenchymal transition process during cancer progression.Molecular Pathways: New Signaling Considerations When Targeting Cytoskeletal Balance to Reduce Tumor Growth.Epithelial-mesenchymal plasticity and circulating tumor cells: Travel companions to metastases.Differential nuclear shape dynamics of invasive andnon-invasive breast cancer cells are associated with actin cytoskeleton organization and stability.Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin.Regulation of epithelial to mesenchymal transition: CK2β on stage.Epithelial-mesenchymal, mesenchymal-epithelial, and endothelial-mesenchymal transitions in malignant tumors: An update.Retinoic acid represses invasion and stem cell phenotype by induction of the metastasis suppressors RARRES1 and LXN.Cytoskeletal organization in microtentacles.Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen.Depletion of JMJD5 sensitizes tumor cells to microtubule-destabilizing agents by altering microtubule stability.Structure-Activity Relationship Studies of β-Lactam-azide Analogues as Orally Active Antitumor Agents Targeting the Tubulin Colchicine Site.Hypermethylation and loss of retinoic acid receptor responder 1 expression in human choriocarcinoma.

P2860

Q24606925-C6F7558A-9672-4030-AA02-896C1704B272 Q24633494-6661E446-CBC6-4F63-B253-A0D3C78AB6C9 Q26859804-1DBEC05D-5998-4E56-A3F4-399862769D73 Q27003285-CFA2B980-945C-4832-B8D5-4E28B629D54F Q27306713-D83E2A4D-04BF-4764-92C1-21AE38BA1FC3 Q27316401-503C861B-3892-49C4-9F72-BB95E831DEDB Q27675177-19B4C417-E3A9-47C5-A734-71612E834D76 Q27676036-314B7E3A-A66E-4532-B800-0C3F58281033 Q28075965-5C6BD7DC-274E-4BBE-9A31-3C36E830241E Q30380965-78CB0AC4-A245-4A4B-8514-E91E9D099C58 Q30408828-1EC8FB8D-D78F-43C0-A6F8-36FD233E1DCA Q33770927-DDA60BE0-6109-4859-90F9-E361D62AE098 Q34541763-E247EC48-2CAF-401A-ADA7-EECB0909345B Q34706189-3E70467D-3BD9-4DF4-82BB-6AF45F75F8E8 Q35151075-E87BAB2D-0872-4FBF-B086-AA572C27DB1A Q35616813-6D435F5F-9589-4A92-80CD-E6BD68A8AC52 Q35767115-9D691484-26DB-496B-B221-CED37422F196 Q36241242-A44558ED-7093-4EF5-AC7E-1B12E5B5C533 Q36260570-ECA3A809-64E4-4CDD-893D-76826ECF451A Q36546637-CA9A8C92-5A9F-4A52-B901-5A0A298D9E7E Q37420601-A5C94515-57FB-4566-9845-677B2BD24F85 Q37654545-423797D7-E67F-4E2D-8000-B5925656B4E2 Q37690655-89D6C90E-CE39-4C20-8857-AC587660FB23 Q37691175-2E01A1A1-0CA7-4CFB-839D-ACBBB8B52F93 Q37708731-F4D9585D-571D-46C3-B64D-0D04343C2747 Q37728193-572945CA-F76E-4E4F-A25D-977599684606 Q38353157-5B1F554F-0442-4926-A274-A29F71C0B509 Q38592713-CA17D436-2B76-4DD7-9813-850A047DB97E Q38606432-4587A1EB-6287-464C-BEE7-0BFF4EE37ABD Q38838108-C17CC0DF-3503-4FFE-810B-A4D5EA11C6ED Q38972545-2E86C678-DC7D-42FB-A189-6EA5D480D645 Q39048777-459655AD-C3D2-4553-BB20-B693176C4F7B Q39507030-8B463B97-E1FD-4187-BCEC-00E58C902B03 Q40245310-04EA20A3-354A-46F2-A67E-08F64C2599A9 Q40289727-47E51BEE-FFA7-4E4D-872E-F103E45A23D5 Q41597783-4319130C-4D8F-46D4-B668-CA62979017C5 Q41809872-24B536BE-9AC3-481F-920C-A5102A12A0F0 Q41817690-F6EBDAA4-B8A1-4F3A-92CD-9670B99F3899 Q42371853-E8031BF1-BA49-4F42-AE48-BF95645F6C88 Q47110757-01FD2F3E-4E5C-4518-AB3A-FEA93C6BF001

P2860

Epithelial-to-mesenchymal transition promotes tubulin detyrosination and microtentacles that enhance endothelial engagement

http://www.wikidata.org/entity/Q34141959

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Epithelial-to-mesenchymal tran ...... enhance endothelial engagement

@ast

Epithelial-to-mesenchymal tran ...... enhance endothelial engagement

@en

Epithelial-to-mesenchymal tran ...... enhance endothelial engagement

@nl

type

label

Epithelial-to-mesenchymal tran ...... enhance endothelial engagement

@ast

Epithelial-to-mesenchymal tran ...... enhance endothelial engagement

@en

Epithelial-to-mesenchymal tran ...... enhance endothelial engagement

@nl

prefLabel

Epithelial-to-mesenchymal tran ...... enhance endothelial engagement

@ast

Epithelial-to-mesenchymal tran ...... enhance endothelial engagement

@en

Epithelial-to-mesenchymal tran ...... enhance endothelial engagement

@nl

P1433

Q34141959-4E18455A-F7CF-42F9-8751-7DF70205E37A

P1476

Q34141959-E693A911-F427-49E5-8A5B-5B94CB07077D

P2093

Q34141959-49A3C38A-B896-4814-BCCA-7BBC1E425270

Q34141959-7B59B5EC-E79B-4227-87AC-A68EC348086B

Q34141959-852C8F19-81EF-4D3D-B565-FDA6849EE3A1

Q34141959-C537A3D2-CD58-4A0B-AFF8-1B5393408920

Q34141959-C83DF697-4987-451E-BB4D-70B1BFAE5F9B

Q34141959-CED8A8B0-1452-4F86-AE17-8C690D5E1614

Q34141959-D16B9DEB-7EDE-4B66-B737-01ED4FF6E6A8

Q34141959-D8CDC824-8150-45CE-9077-FD95C9EF1154

Q34141959-F61870C0-82EF-4455-8D27-4DDC4017F583

Q34141959-FF9F87C9-5481-4097-A755-BB6AC70074EC

P2860

Q34141959-02A73487-1C9B-4C4E-AE96-BCAE880045D2

Q34141959-03E3D1FB-EBA5-406D-835C-237680BFA6B5

Q34141959-09C48820-110B-4368-8222-11E202253C0D

Q34141959-0DACDBC8-E922-4DE3-9209-3EB0856F5D7F

Q34141959-0F9DB48A-400D-4A0E-A77D-FF0BA81A20CC

Q34141959-12F89519-3D87-4EC2-A353-55F28DF30F6B

Q34141959-1705E6FC-4187-4755-9D37-E8219FD51471

Q34141959-174E594B-63A3-46BE-852E-AE4D26E286CA

Q34141959-1CC870EA-D186-4268-9467-DD0F5B745092

Q34141959-2B105DAC-7256-40A0-BBA9-C645FA9DE3B0

P304

Q34141959-2C5455C9-FE81-45C8-A286-D5155F89D137

P31

Q34141959-BD2B1BB0-EF34-4285-BF7B-EFD29A6A2D08

P356

Q34141959-19F42549-03D4-4A29-AC24-B87C9CC4F9B9

P407

Q34141959-318A9720-F381-47AE-98E5-1EBA32FACFBE

P433

Q34141959-93FB4693-FD93-4471-829C-D25DC0445B72

P478

Q34141959-A71021FC-061D-4CDB-A281-9FA92D1857A0

P577

Q34141959-DE875A9A-02C6-4BAD-B8C5-21AE49858D4A

P698

Q34141959-0C76FF4E-44ED-4F5D-B1D3-EBFB7B94908B

P921

Q34141959-BC4F7F2A-91D4-4067-98AA-9C25F1BD8F53

P932

Q34141959-13668BA2-3F36-40A2-9760-187F8D6A14FA

P356

0008-5472.CAN-09-4613

P1433

Cancer Research

P1476

Epithelial-to-mesenchymal tran ...... enhance endothelial engagement

@en

P2093

Edward H Cho

http://www.w3.org/2001/XMLSchema#string

Eric M Balzer

http://www.w3.org/2001/XMLSchema#string

Jennifer R Yoon

http://www.w3.org/2001/XMLSchema#string

Jing Yang

http://www.w3.org/2001/XMLSchema#string

Kimberly C Tuttle

http://www.w3.org/2001/XMLSchema#string

Michael A Matrone

http://www.w3.org/2001/XMLSchema#string

Michele I Vitolo

http://www.w3.org/2001/XMLSchema#string

Olga B Ioffe

http://www.w3.org/2001/XMLSchema#string

Rebecca A Whipple

http://www.w3.org/2001/XMLSchema#string

Stuart S Martin

http://www.w3.org/2001/XMLSchema#string

P2860

Optical deformability as an inherent cell marker for testing malignant transformation and metastatic competence

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

The epithelial-mesenchymal transition generates cells with properties of stem cells

The basics of epithelial-mesenchymal transition

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis

Tubulin tyrosination is a major factor affecting the recruitment of CAP-Gly proteins at microtubule plus ends.

An overview of epithelio-mesenchymal transformation

P304

8127-8137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-09-4613

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20924103

http://www.w3.org/2001/XMLSchema#string

P921

P932

3123454

http://www.w3.org/2001/XMLSchema#string